Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Shares, No Par Value
- Shares outstanding
- 28,495,649
- Total 13F shares
- 68,689,787
- Share change
- +14,493,249
- Total reported value
- $61,801,567
- Put/Call ratio
- 0%
- Price per share
- $0.90
- Number of holders
- 64
- Value change
- +$12,093,920
- Number of buys
- 29
- Number of sells
- 40
Quarterly Holders Quick Answers
What is CUSIP 68235C107?
CUSIP 68235C107 identifies OCX - Oncocyte Corporation - Common Shares, No Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 68235C107:
Top shareholders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
|
Company |
61%
|
17,349,945
|
$25,851,000 | — | 31 Mar 2022 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
43%
|
12,223,953
|
$18,214,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
17%
|
4,933,649
|
$7,351,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
14%
|
3,986,270
|
$5,940,000 | — | 31 Mar 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
12%
|
3,493,800
|
$5,206,000 | — | 31 Mar 2022 | |
| Defender Capital, LLC. |
13F
|
Company |
9%
|
2,562,130
|
$4,001,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
4.8%
|
1,357,513
|
$2,023,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.4%
|
1,266,447
|
$1,887,000 | — | 31 Mar 2022 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
3.5%
|
1,010,700
|
$1,506,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
3.6%
|
1,027,493
|
$1,448,000 | — | 31 Mar 2022 | |
| Penbrook Management LLC |
13F
|
Company |
2%
|
578,150
|
$861,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.9%
|
551,909
|
$822,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.6%
|
460,004
|
$686,000 | — | 31 Mar 2022 | |
| ACT CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
330,000
|
$492,000 | — | 31 Mar 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.86%
|
245,850
|
$366,000 | — | 31 Mar 2022 | |
| AWM Investment Company, Inc. |
13F
|
Company |
0.85%
|
241,867
|
$360,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.75%
|
213,082
|
$317,000 | — | 31 Mar 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.72%
|
205,300
|
$306,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.69%
|
196,065
|
$292,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.56%
|
160,186
|
$239,000 | — | 31 Mar 2022 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.55%
|
158,004
|
$235,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.55%
|
157,450
|
$235,000 | — | 31 Mar 2022 | |
| Cinctive Capital Management LP |
13F
|
Company |
0.49%
|
140,925
|
$210,000 | — | 31 Mar 2022 | |
| Fort Sheridan Advisors LLC |
13F
|
Company |
0.47%
|
135,000
|
$201,000 | — | 31 Mar 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.35%
|
100,232
|
$149,000 | — | 31 Mar 2022 | |
| NISA INVESTMENT ADVISORS, LLC |
13F
|
Company |
0.3%
|
84,368
|
$126,000 | — | 31 Mar 2022 | |
| CALIBER WEALTH MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
75,120
|
$112,000 | — | 31 Mar 2022 | |
| IFP Advisors, Inc |
13F
|
Company |
0.11%
|
32,001
|
$106,000 | — | 31 Mar 2022 | |
| LPL Financial LLC |
13F
|
Company |
0.24%
|
68,816
|
$103,000 | — | 31 Mar 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.21%
|
60,355
|
$90,000 | — | 31 Mar 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.18%
|
51,195
|
$77,000 | — | 31 Mar 2022 | |
| Li Yu |
3/4/5
|
VP Cntrllr/Prncpl Acctng Offcr |
—
mixed-class rows
|
41,872
mixed-class rows
|
$76,536 | — | 18 May 2022 | |
| STRS OHIO |
13F
|
Company |
0.18%
|
50,300
|
$74,000 | — | 31 Mar 2022 | |
| WEALTH EFFECTS LLC |
13F
|
Company |
0.17%
|
49,000
|
$73,000 | — | 31 Mar 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.15%
|
41,578
|
$62,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.14%
|
40,860
|
$61,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.14%
|
39,914
|
$59,000 | — | 31 Mar 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.13%
|
37,782
|
$56,295 | — | 31 Mar 2022 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.13%
|
37,100
|
$55,000 | — | 31 Mar 2022 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.13%
|
36,073
|
$54,000 | — | 31 Mar 2022 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.1%
|
29,874
|
$45,000 | — | 31 Mar 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.1%
|
28,903
|
$43,000 | — | 31 Mar 2022 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.1%
|
27,904
|
$42,000 | — | 31 Mar 2022 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.09%
|
25,949
|
$39,000 | — | 31 Mar 2022 | |
| MML INVESTORS SERVICES, LLC |
13F
|
Company |
0.09%
|
25,500
|
$38,000 | — | 31 Mar 2022 | |
| DCF Advisers, LLC |
13F
|
Company |
0.09%
|
25,149
|
$37,000 | — | 31 Mar 2022 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.08%
|
24,078
|
$35,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.08%
|
22,213
|
$33,000 | — | 31 Mar 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.08%
|
21,653
|
$32,000 | — | 31 Mar 2022 | |
| ProShare Advisors LLC |
13F
|
Company |
0.07%
|
20,825
|
$31,000 | — | 31 Mar 2022 |
Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q2 2022
As of 30 Jun 2022,
Oncocyte Corporation - Common Shares, No Par Value (OCX) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,689,787 shares.
The largest 10 holders included
BROADWOOD CAPITAL INC, PURA VIDA INVESTMENTS, LLC, AWM Investment Company, Inc., VANGUARD GROUP INC, ORBIMED ADVISORS LLC, Defender Capital, LLC., BlackRock Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and Schonfeld Strategic Advisors LLC.
This page lists
64
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
76
Q2 2022 holders
64
Holder diff
-12
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.